Back
Annaly Capital Management, Inc. Vs. Travere Therapeutics, Inc. Industry Stock Comparison
Buy
57
NLY
Annaly Capital Management, Inc.
Last Price:
$23.14
Seasonality Move:
0.17%
Buy
78
TVTX
Travere Therapeutics, Inc.
Last Price:
$39.6600
Seasonality Move:
33.23%
Buy
57
Annaly Capital Management, Inc. (NLY)
is a Buy
Is Annaly Capital Management, Inc. a Buy, Sell or Hold?
-
The current Annaly Capital Management, Inc. [NLY] share price is $23.14. The Score for NLY is 57, which is 14% above its historic median score of 50, and infers lower risk than normal.
-
NLY is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
78
Travere Therapeutics, Inc. (TVTX)
is a Buy
Is Travere Therapeutics, Inc. a Buy, Sell or Hold?
-
The current Travere Therapeutics, Inc. [TVTX] share price is $39.6400. The Score for TVTX is 78, which is 56% above its historic median score of 50, and infers lower risk than normal.
-
TVTX is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
NLY Stock Price Chart
What is Annaly Capital Management, Inc.'s stock price today?
-
The Annaly Capital Management, Inc. share price today is $23.14Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and NLY is experiencing slight selling pressure.
TVTX Stock Price Chart
What is Travere Therapeutics, Inc.'s stock price today?
-
The Travere Therapeutics, Inc. share price today is $39.6400Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and TVTX is experiencing slight selling pressure.
NLY Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.29 | Buy |
| Relative Strength Index (14 RSI): | 62.59 | Buy |
| Chaikin Money Flow: | -2177614 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (22.15 - 22.97) | Buy |
| Bollinger Bands (100): | (20.73 - 22.29) | Buy |
TVTX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 10.28 | Buy |
| Relative Strength Index (14 RSI): | 66.31 | Buy |
| Chaikin Money Flow: | -583105 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (33.9202 - 36.9202) | Buy |
| Bollinger Bands (100): | (20.9405 - 34.5405) | Buy |
NLY Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 22.8 | Buy |
| 20-day SMA: | 22.67 | Buy |
| 50-day SMA: | 21.94 | Buy |
| 200-day SMA: | 20.55 | Buy |
| 8-day EMA: | 22.9 | Buy |
| 20-day EMA: | 22.61 | Buy |
| 50-day EMA: | 22.1 | Buy |
| 200-day EMA: | 20.96 | Buy |
TVTX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 36.31 | Buy |
| 20-day SMA: | 35.4 | Buy |
| 50-day SMA: | 33.69 | Buy |
| 200-day SMA: | 22.3 | Buy |
| 8-day EMA: | 30.99 | Buy |
| 20-day EMA: | 18.54 | Buy |
| 50-day EMA: | 8.93 | Buy |
| 200-day EMA: | 2.46 | Buy |
Annaly Capital Management, Inc. Earnings Growth & NLY Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.02 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.26 per share, and an increase next year of $0.07 per share.
Travere Therapeutics, Inc. Earnings Growth & TVTX Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.54 per share, a decrease next quarter of $0.00 per share, an increase this year of $3.58 per share, and an increase next year of $1.08 per share.
Annaly Capital Management, Inc. Technical Analysis
| Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 23 | Dec 24 | Dec 26 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 12 | 15 | 16 | 17 | 18 | 19 | 22 | 23 | 24 | 26 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Travere Therapeutics, Inc. Technical Analysis
| Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 23 | Dec 24 | Dec 26 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 12 | 15 | 16 | 17 | 18 | 19 | 22 | 23 | 24 | 26 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||